Bit of a quiet period for this stock after the recent capital raise, but at some point this stock will fly. USA trial to be complete by the end of the year. Cash in the bank, catalyst ahead. 45 cent base. Pioneer Capital Fund letter of intent to invest another 8 million at 60 US cents. Other biotechs catching a bid. Don't really see much downside from here.
Ann: Ethics Committee Approval by ICPS for VISABL-AFL Trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.030(2.33%) |
Mkt cap ! $403.7M | |||
| Open | High | Low | Value | Volume |
| $1.34 | $1.34 | $1.26 | $263.0K | 206.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 16000 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 25000 | 1 |
View Market Depth
| Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
| IMR (ASX) Chart |